Skip Ribbon Commands
Skip to main content
Sign In
Navigate Up

25486 Prostaglandin D2 (FD2PG)

Prostaglandin D2 (FD2PG)
Test Code: FPGD2SO
Synonyms/Keywords
​PGD2
Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)		 Pediatric Minimum Volume
(no repeat)​​
​ ​ ​ ​ ​ ​ ​Submit only 1 of the following specimens​:
No​ ​Serum ​Red Top Tube (RTT) ​Serum Separator Tube (SST) ​3 mL ​1 mL ​
Collection Processing Instructions
​Patient should not be on aspirin, indomethacin, or anti-inflammatory medications, if possible, for at least 48 hours prior to collection of specimen.  Separate serum or plasma immediately and label specimen appropriately.
Specimen Stability Information
Specimen Type Temperature T​​ime
​Serum ​Frozen ​60 days
Rejection Criteria
Thawed specimen
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instru​​mentation
Mayo Medical Laboratories
who forwards to Interscience Institute​		 ​Monday throgh Friday ​10-12 days EIA/ELISA
Reference Lab
Mayo Clinic Laboratories
Test Information

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

​Reference lab:
Interscience Institute
644 West Hyde Park Blvd
Inglewood, CA 90302
Reference Range Information
Performing Location Reference Ra​​nge
​Interscience Institute ​35-115 pg/mL
No pediatric reference ranges available for this test​ ​
Outreach CPTs
CPT Modifier
(if needed)		 Quantity Description Com​​ments
​84150 ​ ​ ​ ​
Classification

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

​
Synonyms/Keywords
​PGD2
Ordering Applications
Ordering Application Descr​​iption
C​linical Order Manager ​Prostaglandin D2 (PGD2)
​Centricity ​Prostaglandin D2 (PGD2)
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)		 Pediatric Minimum Volume
(no repeat)​​
​ ​ ​ ​ ​ ​ ​Submit only 1 of the following specimens​:
No​ ​Serum ​Red Top Tube (RTT) ​Serum Separator Tube (SST) ​3 mL ​1 mL ​
Collection Processing
​Patient should not be on aspirin, indomethacin, or anti-inflammatory medications, if possible, for at least 48 hours prior to collection of specimen.  Separate serum or plasma immediately and label specimen appropriately.
Specimen Stability Information
Specimen Type Temperature T​​ime
​Serum ​Frozen ​60 days
Rejection Criteria
Thawed specimen
Reference Range Information
Performing Location Reference Ra​​nge
​Interscience Institute ​35-115 pg/mL
No pediatric reference ranges available for this test​ ​
For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instru​​mentation
Mayo Medical Laboratories
who forwards to Interscience Institute​		 ​Monday throgh Friday ​10-12 days EIA/ELISA
Reference Lab
Mayo Clinic Laboratories
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)		 Quantity Description Com​​ments
​84150 ​ ​ ​ ​
Classification

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

​
For most current information refer to the Marshfield Laboratory online reference manual.